Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Reflections on the AGM
View:
Post by ONCInvestor on May 16, 2024 11:01pm

Reflections on the AGM

Virtual AGMs are awful and that's reflected in the mediocre Q&A where management simply amalgamated shareholder questions into a few generic questions and then provided generic answers. I would be very curious to read the actual questions that were submitted.

The directors should be embarrassed by the voting results--assuming that they're even capable of embarrassment, that is. Usually directors win with high-80s to mid-90s. Outside of a proxy contest it's highly unusual to see results in the 70s. Matt barely broke 70%. I think that's an indictment of the board and of management. Shareholders only hope at this point is that the directors (especially the newer ones) care enough about their reputations to take some action. Seriously. I really think that.

More generally, Matt and Kirk should be fired. I know that some have been saying that for a while, but I think it's true. They can't execute. It doesn't matter how good your idea is, or how good your product is, if you can't execute, then it's worthless. And they have no credibility. I literally do not believe any timeline that they provide. Just in the past 9 months: (i) failed PanCan and delay in relaying that information to shareholders; (ii) commencing a Phase III in pancreatic by end of H1 (I believe that was in a corporate presentation at the beginning of the year); (iii) Phase IIIs are now mysteriously "registration-enabling studies". And let's not forget the many and ongoing "partnership discussions". And if we go back 12 months, I would add in Bracelet where (I believe) they blew the trial design on the CPI arm.

I've long thought that if this company had a longer operating history and better management, that we would be worth a lot more. As it is, that time is past.  The board should do it's job and find a CEO who either, (i) has demonstrated experience in getting a drug through the Phase III process, or (ii) can package the company for sale. Personally, I would be quite happy with a $4-5 buy-out at this point.
Comment by Lesalpes29 on May 17, 2024 7:22am
If I understand the last developments we are in for an other year of slow progress. Difficult to see any buyout this year without a partnership with $ sign in the next 2-3 months. Patience is getting shorter but we have some positives posters maybe they will be right one day!
Comment by lonc17 on May 17, 2024 1:32pm
Well said, ONCInvestor. Sadly, MC has stacked the BOD, and they are all feeding from the same trough, so it seems very unlikely that either he or his good friend Kirk will ever be fired. Most likely, they both get large bonuses and another boatload of options at the end of 2024 after leading ONC through yet another "outstanding" ...more  
Comment by lonc17 on May 17, 2024 1:33pm
Well said, ONCInvestor. Sadly, MC has stacked the BOD, and they are all feeding from the same trough, so it seems very unlikely that either he or his good friend Kirk will ever be fired. Most likely, they both get large bonuses and another boatload of options at the end of 2024 after leading ONC through yet another "outstanding" year of amazing progress. How unfortunate that every ...more  
Comment by Azzak34 on May 17, 2024 2:08pm
Someone has never read the forward looking statements on every single corporate presentation. And it's free *reign*!!! How unfortunate that every corporate presentation can be prefaced with a disclaimer about "forward-looking statements"
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities